| Prev Close | 241.66 |
| Day Low/High | 240.02 / 246.84 |
| 52 Wk Low/High | 177.05 / 264.97 |
Amgen Inc. (AMGN)
245.49
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 582.17B |
| Market Cap | 140.69B |
| P/E Ratio | 19.16 |
| Div & Yield | N.A. (N.A) |
Latest News
My 10 'No Doubt' Predictions for 2021
From Amazon to Zoom, here are my prognostications and best ideas for the new year.
Let's See How These Dividend Gifts Stack Up
Let's compare several dividend increases in time for the holidays -- and see who wins the 'derby.'
Bearish Bets: 2 Nasdaq Stocks You Should Consider Shorting This Week
These names are displaying technical deterioration.
A 3% Dividend Yield With Growth in the Pipeline
With four consecutive flat quarterly dividends, this pharmaceutical name could be on the verge of another hefty raise.
Real Money Post Industrial Average Rises 21% Year to Date
The average declined in October, but it was less than that hit took by the major indexes.
Surviving in This Environment, Shaky Recovery, Lilly and Pfizer Setbacks
The 'work from home' or 'economic lockdown' trade is close to being back on.
Eli Lilly Could Rally After Passing the Test
Successful tests of a rising 200-day moving average line can be great entry points for longs.
No Ordinary Month, Fear September?, Put/Call Ratio, TikTok Bidding War, Amazon
How September markets digest August ahead of momentous events will be far more important to uptrend maintenance than how August closed.
Pizza, Splits and Stocks
Apple's weight in the (price-weighted) Dow Jones Industrial Average, effective this morning, will be reduced from 12% to 3% -- based on the company's 4-1 stock split. In response to that split, Amgen , Honeywell , and Salesforce are being added to t...
Weakness in September? Dwindling Trading Volume, Fed Speak, Cybersecurity Stocks
September, not October, is historically the weakest month of the year for equity markets, though October has had more high profile collapses.
A Healthy Dose of Vaccine and Pharmaceutical Plays
6 favorite stocks and ETFs in the biotech and pharmaceutical sector, including a diversified basket of Covid-19 vaccine names.
Amgen Might Be the Right Medicine for the Dow
Let's check the charts as this biotech replaces Pfizer on the DJIA.
Jim Cramer: All These Stocks Are Not Quite 'Dow and Out'
Let's look at the Dow Jones' swapping of Exxon for Salesforce, Pfizer for Amgen and Raytheon for Honeywell.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Here's Something to Try if You're Looking to Get Long Honeywell
What I see: This stock responds well to economic recovery.
Apple Still King, Dow Shell Game, More Market Faith, Renewed China Talks?
Monday's market action was in no way similar to that recent disparity between the 'haves' and 'have nots.'
Danger Beneath the Waves, Chip Stocks Ahoy, Fiscal Battle, Sizing Up Starbucks
Negotiations on the next round of stimulus, more so than tension between Washington and Beijing, and more so than earnings season, will control short-term financial market performance.
SPACs Aren't Just for Trading: 2 Attractive Buy and Hold Opportunities
I like putting some of my money with incredibly successful folks who are well-connected and have a history of success.
Regeneron, PayPal, Facebook Push Up Real Money Post Industrial Average
The RMPIA rose 3.2% for May and 3.3% for the first five months of 2020.
Buffett's Great Airline Escape, Tech Leadership, ECB Wiggle Room
Don't just follow the herd, time your exits and entrances well -- even if it is a big player like Warren Buffett that is leading the charge.
Trading Volumes Rising, GDP Forecasts, Earnings and Trading Thoughts
Market leadership may be lacking on Thursday despite rising trading volumes, plus an update on Apple, Microsoft, Mastercard, Amazon and Gilead.
Amgen Looks Set to Soar to New Heights - Despite the Naysayers
Here's how to play the biotech with earnings on the horizon.
The Market Refuses to Embrace Negatives as Major Earnings Reports Roll In
So far, earnings season has not been the obstacle that many have feared.
Jim Cramer: Here Are the Stocks That 'Transom' Money Is Buying
They buy and buy and buy. The same stocks. Over and over. No end to it.
Real Money Post Industrial Average Leads, but Coronavirus Adds Uncertainty
RMPIA ended January up 0.8%, but now the damage from the Wuhan virus is weighing on the future.
